NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
Skeletal muscle relaxants are a heterogeneous group of medications commonly used to treat two different types of underlying conditions: spasticity from upper motor neuron syndromes and muscular pain or spasms from peripheral musculoskeletal conditions. The purpose of this report is to determine whether there is evidence that one or more skeletal muscle relaxant is superior to others in terms of efficacy or safety.
Contents
- Introduction
- Methods
- Results
- Overview of included studies
- Overview of systematic reviews and trials in patients with spasticity
- Overview of systematic reviews and trials in patients with musculoskeletal conditions
- 1. What is the comparative efficacy of different muscle relaxants in reducing symptoms and improving functional outcomes in patients with a chronic neurologic condition associated with spasticity, or a chronic or acute musculoskeletal condition with or without muscle spasms?
- 2. What are the comparative incidence and nature of adverse effects (including addiction and abuse) of different muscle relaxants in patients with a chronic neurologic condition associated with spasticity, or a chronic or acute musculoskeletal condition with or without muscle spasms?
- 3. Are there subpopulations of patients (specifically by race, age, sex, or different underlying conditions) with spasticity or chronic musculoskeletal conditions for which one skeletal muscle relaxant is more effective or associated with fewer adverse effects?
- Summary
- References
- Appendixes
- Evidence Tables
The purpose of this report is to make available information regarding the comparative effectiveness and safety profiles of different drugs within pharmaceutical classes. Reports are not usage guidelines, nor should they be read as an endorsement of, or recommendation for, any particular drug, use or approach. Oregon Health & Science University does not recommend or endorse any guideline or recommendation developed by users of these reports.
- Review Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.[J Pain Symptom Manage. 2004]Review Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review.Chou R, Peterson K, Helfand M. J Pain Symptom Manage. 2004 Aug; 28(2):140-75.
- Review Muscle Relaxants.[LiverTox: Clinical and Researc...]Review Muscle Relaxants.. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012
- Review Choosing a skeletal muscle relaxant.[Am Fam Physician. 2008]Review Choosing a skeletal muscle relaxant.See S, Ginzburg R. Am Fam Physician. 2008 Aug 1; 78(3):365-70.
- Review Skeletal muscle relaxants.[Pharmacotherapy. 2008]Review Skeletal muscle relaxants.See S, Ginzburg R. Pharmacotherapy. 2008 Feb; 28(2):207-13.
- Review Traumatic Brain Injury (TBI)-Induced Spasticity: Neurobiology, Treatment, and Rehabilitation.[Brain Neurotrauma: Molecular, ...]Review Traumatic Brain Injury (TBI)-Induced Spasticity: Neurobiology, Treatment, and Rehabilitation.Bose P, Hou J, Thompson FJ. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. 2015
- Drug Class Review: Skeletal Muscle RelaxantsDrug Class Review: Skeletal Muscle Relaxants
Your browsing activity is empty.
Activity recording is turned off.
See more...